Clinical Trials

NCT03899883 | COMPLETED | PHASE2
11 participants

Uric Acid Lowering Trial in Youth Onset T2D

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-28
Start Date:
2020-01-01
Completion:
2023-04-13
Conditions
  • Diabetic Kidney Disease
  • Hyperuricemia
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Type2 Diabetes
  • Type 2 Diabetes Mellitus
  • Diabetic Nephropathies
  • Diabetes Complications
Interventions
  • DRUG
NCT03784326 | ACTIVE_NOT_RECRUITING | PHASE2
43 participants

Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-28
Start Date:
2019-02-19
Completion:
2026-12-31
Conditions
  • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage III Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8
  • Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8
  • Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage II Esophageal Adenocarcinoma AJCC v8
  • Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8
  • Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8
  • Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage III Esophageal Adenocarcinoma AJCC v8
  • Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8
  • Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8
  • Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
Interventions
  • DRUG
  • PROCEDURE
No Results Yet
NCT03180502 | ACTIVE_NOT_RECRUITING | PHASE2
120 participants

Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-28
Start Date:
2018-01-23
Completion:
2026-07-13
Conditions
  • Anaplastic Astrocytoma
  • Anaplastic Oligoastrocytoma
  • Anaplastic Oligodendroglioma
  • Diffuse Astrocytoma
  • Glioma
  • Oligoastrocytoma
  • Oligodendroglioma
  • WHO Grade 3 Glioma
Interventions
  • PROCEDURE
  • RADIATION
  • OTHER
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page